Point72 Hong Kong’s ImageneBio Inc IMA Stock Holding History

Point72 Hong Kong’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$4K	–	2145
2022 Q1	$4K	Buy	+50	New	+$5.32K	﹤0.01%	1694

Other funds holding IMA

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Hong Kong's IMA Position: Q2 2022 in Review

Point72 Hong Kong sold out of ImageneBio Inc (IMA) in Q2 2022, closing a stake of 50 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in IMA in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 46 funds tracked by Wall St. Rank hold IMA as of Q2 2022.

Point72 Hong Kong reported no remaining ImageneBio Inc position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 50 ImageneBio Inc shares in Q2 2022, an estimated $4K.
Point72 Hong Kong first reported a position in ImageneBio Inc in Q1 2022 and held it in 1 quarter.
Point72 Hong Kong's ImageneBio Inc position peaked at $4K in Q1 2022.
46 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.